|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 19/00 | |
| A61K 39/00 | |||
| A61K 39/155 | |||
| A61K 39/295 | |||
| A61K 9/107 | |||
| A61K 9/127 | |||
| A61P 31/14 | |||
| A61P 37/04 | |||
| C07K 14/135 | |||
| C12N 15/45 | |||
| C12N 15/62 | |||
| C07K 14/005 | |||
| A61K 39/12 |
| (11) | Patento numeris | 3109258 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16180926.4 |
| Europos patento paraiškos padavimo data | 2008-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-01-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 16524 P | 2007-12-24 | US | |
| 56206 P | 2008-05-27 | US |
| (72) |
BAUDOUX, Jean-Pierre, BE
BLAIS, Normand, CA
RHEAULT, Patrick, CA
RUELLE, Jean-Loius, BE
|
| (73) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart,
BE
ID Biomedical Corporation of Quebec, 2323 Boul. du Parc Technologique Ste Foy, Quebec G1P 4R8, CA |
| (54) | RECOMBINANT RSV ANTIGENS |
| RECOMBINANT RSV ANTIGENS |